Simvastatin therapy in patients with hepatic disease
Aim. To assess effectiveness, safety, and tolerability of simvastatin (Vasilip) in patients with IIa and IIb dyslipidemia, as well as with hepatic disease. Material and methods. The analysis included 30 patients receiving Vasilip (20 mg/d). At baseline and after 3, 6, and 14 months of the treatment,...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Russo |
| Udgivet: |
«SILICEA-POLIGRAF» LLC
2007-10-01
|
| Serier: | Кардиоваскулярная терапия и профилактика |
| Fag: | |
| Online adgang: | https://cardiovascular.elpub.ru/jour/article/view/1359 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|